Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6039-6052
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6039
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6039
Figure 1 Global and individual effects of the coronavirus disease 2019 pandemic on liver-related morbidity and mortality.
ACLF: Acute-on-chronic liver failure; AH: Arterial hypertension; ASH: Alcoholic steatohepatitis; CLD: Chronic liver disease; COVID-19: Coronavirus disease 2019; DILI: Drug-induced liver injury; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis; OLT: Orthotopic liver transplantation.
- Citation: Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6039.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6039